EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi



Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi



Antimicrobial Agents and ChemoTherapy 39(2): 314-319



The purpose of the study was to evaluate the interlaboratory agreement of broth dilution susceptibility methods for five species of conidium-forming (size range, 2 to 7 mu-m) filamentous fungi. The methods used included both macro- and microdilution methods that were adaptations of the proposed reference method of the National Committee for Clinical Laboratory Standards for yeasts (m27-P). The MICs of amphotericin B, fluconazole, itraconazole, miconazole, and ketoconazole were determined in six centers by both macro- and microdilution tests for 25 isolates of Aspergillus flavus, Aspergillus fumigatus, Pseudallescheria boydii, Rhizopus arrhizus, and Sporothrix schenckii. All isolates produced clearly detectable growth within 1 to 4 days at 35 degree C in the RPMI 1640 medium. Colony counts of 0.4 times 10-6 to 3.3 times 10-6 CFU/ml (mean, 1.4 times 10-6 CFU/ml) were demonstrated in 90% of the 148 inoculum preparations. Overall, good intralaboratory agreement was demonstrated with amphotericin B, fluconazole, and ketoconazole MICs (90 to 97%). The agreement was lower with itraconazole MICs (59 to 79% median). Interlaboratory reproducibility demonstrated similar results: 90 to 100% agreement with amphotericin B, fluconazole, miconazole, and ketoconazole MICs and 59 to 91% with itraconazole MICs. Among the species tested, the MICs for S. schenckii showed the highest variability. The results of the study imply that it may be possible to develop a reference method for antifungal susceptibility testing of filamentous fungi.

(PDF emailed within 0-6 h: $19.90)

Accession: 002581744

Download citation: RISBibTeXText

PMID: 7726488

DOI: 10.1128/AAC.39.2.314



Related references

Standardizing antifungal susceptibility testing for filamentous fungi A comparative and collaborative evaluation. Abstracts of the General Meeting of the American Society for Microbiology 93(0): 528, 1993

Comparative evaluation of alternative methods for antifungal susceptibility testing of filamentous fungi. Infeksiyon Dergisi = Turkish Journal of Infection 12(3): 407-411, 1998

Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. Journal of Antimicrobial ChemoTherapy 50(5): 719-722, 2002

Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans. Journal of Clinical Microbiology 39(4): 1345-1347, 2001

Second NCCLS evaluation of antifungal susceptibility testing of filamentous fungi. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35(0): 73, 1995

Evaluation of Etest for antifungal susceptibility testing of filamentous fungi. Abstracts of the General Meeting of the American Society for Microbiology 96(0): 85, 1996

Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clinical Microbiology and Infection 13(10): 1018-1022, 2007

Multicenter evaluation of standardized inoculum for antifungal susceptibility testing of filamentous fungi. Abstracts of the General Meeting of the American Society for Microbiology 93(0): 529, 1993

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. Journal of Clinical Microbiology 35(1): 139-143, 1997

Evaluation of antifungal susceptibility testing for filamentous fungi assayed by broth microdilution and Etest. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 483, 1998

An evaluation of different inoculum densities, incubation periods and MIC endpoint determination methods for antifungal susceptibility testing of filamentous fungi. Abstracts of the General Meeting of the American Society for Microbiology 95(0): 104, 1995

Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi. Journal of Clinical Microbiology 45(4): 1322-1324, 2007

Evaluation of Etest performed in Mueller-Hinton agar supplemented with glucose for antifungal susceptibility testing of clinical isolates of filamentous fungi. Mycopathologia 177(3-4): 157-166, 2014

Antifungal Susceptibility Testing of Filamentous Fungi. Current Fungal Infection Reports 6(1): 41-50, 2012

The Etest for antifungal susceptibility testing of opportunistic filamentous fungi. Abstracts of the General Meeting of the American Society for Microbiology 96(0): 47, 1996